The 12th HTAsiaLink Annual Conference, held on 19–22 August 2025 in Singapore, attracted health technology assessment (HTA) experts from across the Asia-Pacific region. The event welcomed over 450 participants from 98 organizations and showcased 175 abstracts, alongside three plenary sessio

As a Coordinator at the International Unit of the Health Intervention and Technology Assessment Program (HITAP), Piyaphat supports regional and global initiatives that strengthen health systems through evidence-informed policymaking. With a background in liberal arts and professional experience across the humanitarian, public, and private sectors,

Situation of Clean Air Rooms and Air Purifiers in Thailand Thailand continues to experience persistent fine particulate matter with a diameter of 2.5 micrometers or less (PM2.5), posing significant risks to public health, particularly among vulnerable populations. About 13.6 mill

This article is part 1 of the blog series: “Knowledge Translation: The Key to Turning Mathematical Models from a Black Box into a Powerful Tool for Policy Decision-Making” As health systems become more complex, decision-makers need tools that can help them evaluate long-term outcomes and choose

The report summarises a visit to Tanzania and has been prepared by Mr. Panupong Chaowanasawat and Dr. Brandon Chua from the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. The study visit was supported by the Access and Delivery Partnership (ADP), led by the Unite

HITAP was invited to attend the “Strengthening Health and Disease Modelling for Public Health Decision Making” organised by the Bill and Melinda Gates Foundation (BMGF) and Wellcome on June 7–8, 2023 in Kigali, Rwanda. It brought together 110 virtual and on-site attendees, with 76 on-site modellers,

Countries across Asia are increasingly turning to health technology assessment (HTA) to ensure healthcare decisions are guided by appropriate evidence. However, many still face challenges in institutionalizing HTA, including building technical expertise, applying economic evaluation in decision-maki

Dr. Arpaporn Sutipatanasomboon is experienced in cell biology and molecular genetics research and is a registered patent agent with the Thailand Department of Intellectual Property. Her passion is to integrate early health technology assessment and intellectual property management to support decision makers, innovators and promote access to innovat

Dr. Teerawat Wiwatpanit is a biomedical scientist by training. His expertise includes early health technology assessment, innovation development, and biomedical engineering for disease modeling and drug testing. He is passionate about promoting an efficient innovation landscape and translating scientific discoveries into practical healthcare soluti

Asst. Prof. Dr. Wang Yi is a co-founder of Medical Innovation Development and Assessment Support (MIDAS). His research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is als